शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BLUEJETBSEBLUE JET HEALTHCARE LTD· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 3 Aug, 2026 · 12:54 IST

Q1 FY27 results dip YoY; dividend, director and auditor re-appointments approved

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.8%Reaction day
₹625.00
prior close
₹594.00
announcement price
In-mkt
timing
Nifty Smallcap 250market+1.4%-7.2% vs market
Pharmaceuticals peers, median of 163sector+1.0%-6.8% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Smallcap 250 and 6.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.0
10m
-0.3
15m
+0.3
30m
-0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.8+1.4-7.2+1.0-6.8
Next day
-6.7+1.5-8.3+0.8-7.5
2d
-4.8+2.2-7.0+0.3-5.1
3d
-5.9+2.4-8.4+0.7-6.7
4d
-5.1+2.4-7.6+1.5-6.6
5d
-5.3+2.4-7.7+1.3-6.6
1w
-5.9+2.3-8.2+1.6-7.6
15d
-5.4+2.5-8.0+0.9-6.3
1m
-7.5+2.9-10.4+1.7-9.2
2m
-14.8-1.5-13.3+1.9-16.7
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Jet Healthcare Q1 FY27 (June 2026) revenue from operations fell to Rs. 2,931.13 million from Rs. 3,547.58 million in Q1 FY26. PAT declined to Rs. 782.64 million from Rs. 911.70 million. EPS stood at Rs. 4.51 vs Rs. 5.26. Board set September 14, 2026 as record date for Rs. 1.2 per share (60%) dividend for FY26. Re-appointed Chairman Akshay Arora and MD Shiven Arora for 5 years each. KKC and Associates re-appointed as statutory auditors for a second term. 58th AGM scheduled for September 21, 2026.

Likely market impact

Revenue and profit declined YoY but firm stays profitable; steady dividend signals management confidence in cash flows.